Abstract Resveratrol is a polyphenol that is mainly found in grapes and red wine and has been reported to be a caloric restriction (CR) mimetic driven by Sirtuin 1 (SIRT1) activation. Resveratrol increases metabolic rate, insulin sensitivity, mitochondrial biogenesis and physical endurance, and reduces fat accumulation in mice. In addition, resveratrol may be a powerful agent to prevent age-associated neurodegeneration and to improve cognitive deficits in Alzheimer's disease (AD). Moreover, different findings support the view that longevity in mice could be promoted by CR. In this study, we examined the role of dietary resveratrol in SAMP8 mice, a model of age-related AD. We found that resveratrol supplements increased mean life expectancy and maximal life span in SAMP8 and in their control, the related strain SAMR1. In addition, we examined the resveratrol-mediated neuroprotective effects on several specific hallmarks of AD. We found that longterm dietary resveratrol activates AMPK pathways and pro-survival routes such as SIRT1 in vivo. It also reduces cognitive impairment and has a neuroprotective role, decreasing the amyloid burden and reducing tau hyperphosphorylation.
Introduction
Resveratrol (trans-3,4′,5-trihydroxystilbene), a naturally occurring polyphenol mainly found in grapes and red wine, has been reported as a caloric restriction (CR) mimetic with potential anti-aging and antidiabetogenic properties. Resveratrol increases metabolic rate, insulin sensitivity, mitochondrial biogenesis and physical endurance, and reduces fat accumulation in mice (Lagouge et al. 2006; . The most widely accepted mechanistic hypothesis is that resveratrol's effects, in the same way as CR, are driven through Sirtuin 1 (SIRT1) regulation . Although there has been major controversy about whether resveratrol can be an activator of SIRT1, as its ability to interact directly with SIRT1 has been questioned (Beher et al. 2009; Pacholec et al. 2010) , it now seems clear that resveratrol activates SIRT1 indirectly (Villalba et al. 2012) . It is widely accepted that resveratrol benefits are mediated through AMPK activation (Zang et al. 2006; Price et al. 2012) . Thus, resveratrol leads to increases in the NAD-to-NADH cell ratio, which results in activation of AMPK in vivo, initiating a signaling process that regulates insulin sensitivity and recruits mediators of oxidative metabolism and mitochondrial biogenesis, including PGC1α, PPARδ, and others (Um et al. 2010; Ruderman et al. 2010) .
Several findings support the view that longevity can be promoted by CR in mice (Weindruch & Walford, 1988; Selman et al. 2008) , along with CR's broad antiaging activity (Park et al. 2009 ). In recent years, interesting studies in nonhuman primates have reported that CR also extended their life span (Colman et al. 2009 ), but in a very recently published study of the same species CR was not able to do so (Mattison et al. 2012) . Though unlikely, the possibility that CR may extend maximum life span has still not been ruled out. Similarly, resveratrol treatment has a range of beneficial effects in mice, but up to now has failed to increase the longevity of ad libitum-fed animals when started midlife , although in combination with other anti-aging strategies such as CR, it increased mean and maximal life span compared to control animals (Pearson et al. 2008 ). In addition, dietary resveratrol mimics the effects of CR in insulin-mediated glucose uptake in muscle in aged animals, and gene expression profiling suggests that both CR and resveratrol may retard some aspects of aging through alterations in chromatin structure and transcription (Halagappa et al. 2007; Barger et al. 2008) .
Several in vitro and in vivo studies also support the hypothesis that resveratrol may be a powerful agent in preventing age-associated neurodegeneration (Vingtdeux et al. 2008) . In in vitro models, resveratrol markedly lowers the levels of secreted and intracellular amyloidbeta (Aβ) peptides (Marambaud et al. 2005) . Similarly, with a grape seed polyphenolic extract administered orally to Tg2576 mice, a murine model of Alzheimer's disease (AD) (Hsiao et al. 1996) improves cognitive deficits. These effects correlate with reductions in the amounts of high molecular weight Aβ assemblies in the brain . Similar findings have been observed in animals after moderate consumption of red wines Ho et al. 2009 ). Recently, it was shown that resveratrol selectively remodels soluble oligomers, fibrillar intermediates, and amyloid fibrils into alternative aggregated species that are nontoxic (Ladiwala et al. 2010) . These studies and others support the theory that resveratrol or polyphenol derivatives could be useful therapeutic agents for AD . Nevertheless, it is unknown whether resveratrol has similar effects in age-related models of AD.
To this end, we used the age-accelerated mouse (SAMP8). This strain is characterized by deficits in learning and memory (Takeda et al. 1981; Miyamoto et al. 1986; Takeda 2009) , emotional disorders such as reduced anxiety-like behavior (Miyamoto et al. 1992; Markowska et al. 1998) , impaired immune response, etc. (Yagi et al. 1988; Flood & Morley 1998 ). More importantly, this strain is increasingly being recognized as a model of age-related AD (Pallas et al. 2008; Morley et al. 2012) as, in addition to age-related learning and memory impairments, the mice show with aging an ADrelated pathology such as increases in Aβ (del Valle et al. 2010 ) and other protein aggregates , alterations in APP processing by secretases (Morley et al. 2000 (Morley et al. , 2002 , cerebral amyloid angiopathy (del ) and increases in tau hyperphosphorylation (Canudas et al. 2005) .
Therefore, in this study we sought to clarify the role of dietary resveratrol in the SAMP8 mouse. Previous results in SAMP8 demonstrated that low doses and short-term administration of pterostilbene (polyphenolic derivative of resveratrol) show positive effects on behavior, reductions in tau phosphorylation (Chang et al. 2012 ) and regulation of cascades associated with PPAR alpha. Based on these encouraging findings, we determined the effects of long-term administration of resveratrol on longevity and signaling cellular processes activated by this polyphenol, namely the SIRT1 pathway and AMPK system. We also extended these studies by examining the resveratrol-mediated neuroprotective mechanism in several specifically AD hallmarks present in SAMP8, such as, Aβ accumulation and tau phosphorylation.
Methods

Animals and resveratrol diet
A total of 216 male SAMP8 and SAMR1 animals were used for the survival study. The animals received a standard diet (2018 Teklad Global 18 % Protein Rodent Maintenance Diet, Harlan) or the same diet supplemented with trans-resveratrol (1 g/kg, Mega Resveratrol, Candlewood Stars, Inc., CT, USA), starting at 2 months of age and divided into four groups of 50 to 60 individuals: SAMR1 control (n054), SAMR1 resveratrol (n 052), SAMP8 control (n 050), and SAMP8 resveratrol (n060). For the neurodegeneration studies, two groups of 10-12 SAMP8 mice were fed with the standard diet or the resveratrol diet, starting the supplements at 2 months and killing the animals to obtain tissue samples at 9 months of age. All the animals had food and water ad libitum and were kept in standard conditions of temperature (22±2°C) and 12:12-h light-dark cycles (300 lux/0 lux). Studies were performed in accordance with the institutional guidelines for the care and use of laboratory animals established by the Ethical Committee for Animal Experimentation at the University of Barcelona.
Object recognition test
Nine-month SAMP8 control (P8ctl) and SAMP8 resveratrol (P8rsv) animals were placed in a 90°two-arm, 25-cm-long, 20-cm-high, 5-cm-wide black maze. The 20-cm-high walls could be lifted off for easy cleaning. The light intensity in the middle of the field was 30 lux. The objects to be discriminated were made of plastic (5.25-cm high, object A and 4.75-cm high, object B). For the first 3 days, the mice were individually habituated to the apparatus for 10 min. On the 4th day, the animals were submitted to a 10-min acquisition trial (first trial) during which they were placed in the maze in the presence of two identical novel objects (A+A or B+B) placed at the end of each arm. A 10-min retention trial (second trial) occurred 2 h later. During this second trial, objects A and B were placed in the maze, and the time that the animal explored the new object (tn) and the old object (to) were recorded. A discrimination index (DI) was defined as (tn−to)/(tn+to). In order to avoid object preference biases, objects A and B were counterbalanced so that half of the animals in each experimental group were first exposed to object A and then to object B, whereas the other half saw first object B and then object A. The maze and the objects were cleaned with 96°ethanol between different animals, so as to eliminate olfactory cues.
Brain processing
One day after the object recognition test, 9-month animals were intracardially perfused after being anesthetized with 80 mg/kg of sodium pentobarbital. Afterwards, brains were dissected and separated sagitally in two hemispheres, one for immunohistochemistry and the other for protein extraction. Immunohistochemistry brains were frozen by immersion in isopentane, chilled in dry ice and stored at −80°C until sectioning. Thereafter, frozen brains were embedded in OCT cryostatembedding compound (Tissue-Tek, Torrance, CA), cut into 20-μm-thick sections on a cryostat (Leyca Microsystems, Germany) at −18°C and placed on slides. Slides containing brain sections were fixed with acetone for 10 min at 4°C, allowed to dry at room temperature and then frozen at −20°C until further staining. The cortex and hippocampus of the other hemisphere were dissected and stored at −80°C until protein extraction.
Immunohistochemistry
Slides were allowed to defreeze at room temperature and then rehydrated with phosphate-buffered saline (PBS) for 5 min. Then, brain sections were blocked and permeabilized with PBS containing 1 % bovine serum albumin (BSA, Sigma-Aldrich) and 0.1 % Triton X-100 (Sigma-Aldrich) for 20 min. After two 5-min washes in PBS, the slides were incubated with the primary antibody for Aβ 40 , Aβ 42 , (see Table 1 ) overnight at 4°C. They were then washed again and incubated for 1 h at room temperature in the dark with Alexa Fluor secondary antibody. After washing again, nuclear staining was performed by incubating slides in Hoechst (H-33258, Fluka, Madrid, Spain) at 2 μg/mL in PBS for 10 min at room temperature in the dark. Finally, slides were washed, mounted using Prolong Gold (Invitrogen) anti-fade medium, allowed to dry overnight at room temperature and stored at 4°C. Image acquisition was performed with a fluorescence laser microscope (BX41, Olympus, Germany).
Protein extraction
Cortex and hippocampus were micronized through freezing with liquid nitrogen and grinding with a mortar. For total protein extraction, lysis buffer (50 mM TrisHCl, 150 mM NaCl, 5 mM EDTA, 1 % Triton X-100, pH 7.4) containing complete, Mini, EDTA-free Protease Inhibitor Cocktail (Roche, Mannheim, Germany), and Phosphatase Inhibitor Cocktail 1 (Sigma-Aldrich, St. Louis, MO, USA) were added to micronized tissue and left on ice for 30 min. Then, samples were centrifuged at 10,000×g for 10 min and a supernatant with total protein content was collected. All the protein extraction steps were carried out at 4°C. Protein concentration was determined by the Bradford protein assay.
Western blot
For Western blot analysis, 20 ug of protein were denatured at 95°C for 5 min in sample buffer (0.5 M TrisHCl, pH 6.8, 10 % glycerol, 2 % sodium dodecyl sulfate (SDS), 5 % β-mercaptoethanol, 0.05 % bromophenol blue), separated by SDS-PAGE on 10 % polyacrylamide gels and transferred to Immobilon polyvinylidene difluoride membranes (Millipore, Billerica, MA, USA). The membranes were incubated overnight at 4°C with the primary antibodies (see Table 1 ) diluted with Trisbuffered saline containing 0.1 % Tween 20 (TBS-T) and 5 % BSA. Membranes were then washed and incubated with secondary antibodies (see Table 1 ) with TBS-T for 1 h at room temperature. Protein bands were visualized using a chemiluminescence detection kit (Amersham Biosciences). Band intensities were quantified by densitometric analysis and values were normalized to β-actin.
Statistical analysis
Results were analyzed statistically by GraphPad Prism software. Kaplan-Meier survival curve comparison was performed with the log-rank (Mantel-Cox) test. The other data are presented as mean±SEM, and means were compared with two-tailed, unpaired Student's t test or ANOVA following Tukey's Multiple Comparison Test when necessary. In the object recognition test (ORT) a one-sample t test was used to examine whether single columns were different from zero ones. Statistical significance was attained when P values were <0.05.
Results
Increase in life expectancy due to resveratrol
The survival curves were plotted using the Kaplan-Meier estimator. A shift to the right for the resveratrol groups revealed an increased expectancy of life for animals that had been eating the resveratrol diet. The comparison of the groups using the Mantel-Cox log-rank test indicated that there was a significant difference between the survival curves of the control group vs. the resveratrol group, not only in SAMP8 mice (Fig. 1a, P<0 .0001 among groups, Mantel-Cox log-rank test), but also in SAMR1 animals (Fig. 1b , P< 0.01 among groups, Mantel-Cox log-rank test). In addition, the median life expectancy of our control mice was 10.4 months for SAMP8 mice, significantly lower than the 17.8 months of SAMR1 mice (Fig. 1c ) in previous studies (Takeda 2009 ). However, the SAMP8 resveratrol group showed a life expectancy of approximately 14 months, with an increased life expectancy of more than 33 % over the SAMP8 control mice (Fig. 1c) . Furthermore, SAMR1 mice fed with resveratrol also showed a median life span of 21.8 months, 22 % more than SAMR1 control mice (Fig. 1c) . In addition, maximum life span is the mean of the final 20 % of mice surviving in each group, as determined by the Kaplan-Meier analysis. In comparison with the control groups, both SAMP8 and SAMR1 animals fed with resveratrol significantly increased their maximum life span (Fig. 1d) .
Resveratrol decreases cognitive impairment in SAMP8
We investigated the effects of a 7-month resveratrol food supplement on 9-month-old SAMP8 mice. This is an age when several alterations such as amyloid deposition or cognitive impairment have been reported (Pallas et al. 2008) . We found that, in the ORT, control mice had an impaired memory, as their DI was close to or not different from zero (Fig. 2, P00 .4665, one-sample t test), revealing that there was no preference for the novel object. On the other hand, resveratrol mice had a positive DI different from zero (Fig. 2, P<0 .05, one-sample t test), revealing that their memory was not impaired as they showed greater preference for the novel object than the one already presented. Furthermore, a comparison of the two groups revealed a more protective effect of resveratrol on their memory than in age-matched SAMP8 mice (Fig. 2) .
Resveratrol increases both SIRT1 and AMPK levels while it decreases P53 acetylation Western blot analysis of the cortex and hippocampus of the two groups revealed higher levels of SIRT1 (Fig. 3a, b ) in the animals that had been eating a diet supplemented with resveratrol than in animals eating standard food (control group). In accordance with this observation, the substrate of SIRT1, p53, shows a decrease in its acetylation in these brain areas (Fig. 3c, d ). In addition, higher levels of phosphorylated AMPK (p-AMPK) were found in the cortex of the resveratrol group (Fig. 3e) while no modifications were seen in the AMPK levels (Fig. 3g) . However, while no increment of p-AMPK levels was found in the hippocampus of the resveratrol mice (Fig. 3f) , there were higher AMPK basal levels in these animals than in SAMP8 control mice (Fig. 3h) .
Resveratrol reduces amyloid deposition and favors the non-amyloidogenic pathway in the hippocampus of SAMP8 mice
Immunohistochemistry was performed on brain sections with specific antibodies directed against the Aβ 42 and Aβ 40 to assess whether there were differences between the two groups. Visual analysis revealed amyloid clusters limited only to the hippocampal area, as described before (del Valle et al. 2010) . Figure 4 shows that almost no Aβ granules were present in the resveratrol group while several clusters of Aβ 42 and Aβ 40 granules appeared in the control group (Fig. 4a) . Furthermore, we quantified the amount of amyloid clusters that were present in the hippocampus of the two groups. We found that resveratrol decreased the amount of both Aβ 42 and Aβ 40 accumulations in SAMP8 animals in comparison with SAMP8 control mice (Fig. 4b, c) . In addition, Western blot analysis quantified the levels of two enzymes responsible for the amyloidogenic/non-amyloidogenic processing of APP, the α-(ADAM10) and β-(BACE) secretases. We found that while no alterations were seen in the pro-amyloidogenic BACE enzyme (Fig. 5a, b) , an increase in the non-amyloidogenic ADAM-10 enzyme was found in both the cortex (Fig. 5c ) and the hippocampus (Fig. 5d ) of the resveratrol group.
Resveratrol lowers tau hyperphosphorylation at serine 396 and has a differential effect on kinases of the cortex and the hippocampus
The levels of phosphorylated tau (pTau) at Ser 396 have been described as a reliable marker of the severity of AD (Hu et al. 2002) . Thus, we evaluated the effect of resveratrol on tau phosphorylation levels in the cortex and hippocampus extracts by Western blot, using a tau antibody that detects only the pTau at Ser 396 . As can be seen in Fig. 6 , not only the cortex but also the hippocampus of animals fed with resveratrol showed lower levels of pTau (Fig. 6a, b) . In addition, we investigated the levels of CDK5 and the ratio of its activator p25 to the precursor p35, as well as the phosphorylated levels of GSK3β, CDC2, and JNK. A drop in CDK5 protein levels (Fig. 6c) , together with a decrease in the p25/p35 ratio (Fig. 6e) , revealed inactivation of this kinase in the cortex of resveratrol animals. In addition, an increase in the levels of phosphorylated GSK3β at Ser 9 can be seen (Fig. 7a) , which also correlates with the reduced pTau levels, as this enzyme is deactivated when phosphorylated at this residue. However, no modifications were detected in the levels of phosphorylated CDC2 (Fig. 7c) or in the levels of phosphorylated JNK (Fig. 7e) . Conversely, there were no changes between resveratrol-treated SAMP8 hippocampus and agematched SAMP8 control mice in the kinases studied (Figs. 6d, f and 7b, d, f 
Discussion
The results reported here confirm the positive effect of resveratrol on extending mean and maximum life span, memory, and neurodegenerative markers in the SAMP8 mice.
It has been reported that SIRT1 activation by resveratrol increases the life span of Saccharomyces cerevisiae (Howitz et al. 2003) , Caenorhabditis elegans (Viswanathan et al. 2005) , Drosophila melanogaster (Wood et al. 2004) , and the short-lived seasonal fish Nothobranchius furzeri (Valenzano et al. 2006) . However, discrepancies between labs remain unexplained. The influence of factors such as interspecies differences in metabolism, genetic variation, diet, physical activity, disease, and mental health should not be underestimated when extrapolating from rodent models (for a review, see Agarwal & Baur 2011) . Then, further experimental evidence is needed to clarify the importance of SIRT1 and other mechanisms in the effects of resveratrol.
Here we demonstrate that resveratrol can extend life span in mice. Resveratrol supplement in the diet resulted in a significant increase in mean life expectancy and in maximum life span, in both SAMP8 and SAMR1. At present, resveratrol was reported to prevent early mortality in mice fed with a high-fat diet ) but failed to affect survival significantly in old mice (Miller et al. 2011) . A growth hormone releasing hormone antagonist has been shown to extend SAMP8 mice's median life span (Banks et al. 2010) , which was associated with decreased brain oxidative stress. Melatonin has also been reported to increase life span and longevity in SAMR1 and SAMP8 mice (Rodríguez et al. 2008 ). These authors conclude that the underlying effects of this indoleamine rely on mitochondrial physiology improvement, involving a decrease in reactive oxygen species generation. As old rodents produce more reactive oxygen species than young ones and the rate of mitochondrial reactive oxygen species production is inversely proportional to species' maximum life span, it would be reasonable to expect that an agent that lowered reactive oxygen species might extend life span (Sohal et al. 1989 ). Sirtuins are deacetylases that show anti-aging properties in several animal models and can protect from stress (Donmez et al. 2010) . SIRT1 plays a role in regulating different cell processes through deacetylation of important substrates such as p53, FOXO transcription factors, PGC-1α, NFκB, and others, which are closely linked to some age-related diseases (Saunders et al. 2010 ). SIRT1 activation may play an important role in the life-extending effects of CR (Cohen et al. 2004) , and it has been postulated that resveratrol mimics the effect of CR. In this study, we demonstrated an increase in SIRT1 levels in SAMP8 treated with resveratrol in the two brain areas studied, which correlated with a diminution in acetylated forms of p53, one of the main substrates of deacetylase. In addition, SIRT1 pathways are closely related to AMPK signaling as a sensor of energy availability. AMPK is activated by phosphorylation of Thr-172 by LKB1 complex in response to an increase in the AMP/ATP ratio and by calmodulin-dependent protein inhibition of cAMP-specific phosphodiesterases (Park et al. 2012a, b) . Our results showed that resveratrol activation of SIRT1 in SAMP8 mice correlated with changes in the levels or in the phosphorylation of AMPK, demonstrating again that resveratrol modifies the SIRT1 pathway.
Furthermore, a link between SIRT1 activation, AMPK, and AD is increasingly evident (Gan 2007) . Tau phosphorylation and β-amyloid production are sensitive to AMPK inhibition (Greco et al. 2011; Park et al. 2012a, b) . SIRT1 activation prevents several signs of neurodegeneration (Bayod et al. 2011) , protects against axonal degeneration (Araki et al. 2004) , reduces polyglutamine toxicity (Parker et al. 2005) , and diminishes microglia-mediated Aβ toxicity (Chen et al. 2005) . AD and Aβ accumulation are inextricably linked with oxidative damage (Smith et al. 1995) . Diet supplements with mulberry (a resveratrol-rich fruit) improved not only memory impairment and decreased Aβ accumulation in SAMP8 but also increased antioxidant capacity via the antioxidant response element (ARE)-Nrf2 pathway in the liver and brain (Shih et al. 2010 ). Furthermore, resveratrol has been reported to improve memory alterations as it preserved cognitive function in aging mice (Oomen et al. 2009 ) and in transgenic AD mice (Kim et al. 2007 ). However, although some conflicting results have been obtained on SAMP8 memory alterations (Spangler et al. 2002) , we found memory-related deficits at 9 months of age and that resveratrol was able to revert the memory impairment detected.
Part of the beneficial effects described for SIRT1 on Aβ accumulation is the modulation of α-secretases. Transcription of ADAM10 is positively controlled by retinoic acid receptors (RAR), which are activated by their ligand retinoic acid or through deacetylation by SIRT1. Using SIRT1-transgenic and SIRT1-deficient mice, this protein was found to activate the RARb transcription factor, which in turn increased ADAM10 expression (Lichtenthaler 2011) . In addition, SIRT1 activation reduced amyloid pathology in a mouse model of AD, and crossing SIRT1 knockout mice with these mice dramatically increased the Aβ burden (Donmez et al. 2010) . Moreover, decreased SIRT1 expression has been found in patients with AD, and this decrease correlates with tau and Aβ levels (Julien et al. 2009 ). Modulation of ADAM10 expression by SIRT1 has also been demonstrated (Gutierrez-Cuesta et al. 2008; Donmez et al. 2010 ). In our experimental paradigm, we found that resveratrol reduces the Aβ burden in treated SAMP8 brain concomitantly with increases in ADAM10 expression. This effect can be considered specific because no changes were observed in the expression of other secretases, such as, BACE (Donmez et al. 2010) . Thus, resveratrol, through SIRT1 activation, specifically induced the non-amyloidogenic processing of nonmutated APP, reducing the presence of previously described amyloid deposits (del Valle et al. 2010) .
Furthermore, tau hyperphosphorylation, another hallmark of AD, is mediated by several kinases in the brain. We and others have demonstrated the aberrant phosphorylation of tau in the brain of SAMP8 that is accomplished by activation of several tau kinases such as CDK5, GSK3β, or JNK (Canudas et al. 2005; Chang et al. 2012) . Our data show that in the cortex of SAMP8 mice, a diminution in CDK5 and GSK3β activity, both main tau kinases in AD, is induced by resveratrol treatment, and the inhibition of these tau kinases prevented tau phosphorylation in Ser 396 .
On the other hand, no clear changes in JNK were found. Conversely, with low doses and only 2 months of treatment with pterostilbene, a resveratrol derivative, JNK inhibition was observed in SAMP8, but no changes in tau hyperphosphorylation (measured through PHF antibody) were observed in the cortex (Chang et al. 2011) . All these discrepancies are probably due to the different resveratrol doses and also to the long-term treatment by resveratrol that we applied in the present study.
With regard to the hippocampus, although resveratrol was able to prevent tau phosphorylation, we were unable to find changes in the kinases studied. It is plausible to hypothesize that, although long-term treatment by resveratrol prevents tau hyperphosphorylation, detectable by specific phospho-antibodies, the inhibition of intermediate signals under these conditions is lost because of the chronicity of the treatment. On the other hand, oxidative stress is a well-established pathogenic factor in AD (Smith et al. 1995; Markesbery 1997; Perry et al. 1998) , and the association of oxidative stress with tau abnormalities is well-known. As such, the resveratrol-driven reductions on tau phosphorylation in the hippocampus could be mediated by the well-known antioxidant effects of this polyphenol rather than through its inhibitory effect on tau kinases. Therefore, our results allow us to conclude that resveratrol inhibits tau phosphorylation in both the cortex and hippocampus.
Finally, we cannot discard the possibly beneficial antioxidant effect of resveratrol in the parameters studied here. More studies should be conducted in different AD models in order to clarify the role of resveratrol in SIRT1 and AMPK pro-survival pathways and other oxidative stress routes such as ARENrf2. However, taking everything into account, in this study we demonstrate that resveratrol alone not only increases mean and maximum life span, and favors AMPK pathways and pro-survival routes such as SIRT1 activation, but also has a neuroprotective role, reducing cognitive impairment in AD and other neurodegenerative parameters such as the amyloid burden and tau hyperphosphorylation.
